文献速递眼底病与葡萄膜炎青光眼角膜与眼表疾病

马方综合征的眼部疾病负担:一项全国性流行病学研究

Ocular morbidity in Marfan syndrome: a nationwide epidemiological study.
PubMed 文献 · Br J Ophthalmol · 2022-03-22

该研究利用丹麦全国医疗登记数据,评估407例马方综合征(MFS)患者的眼部疾病负担,并与40700名年龄和性别匹配的背景人群比较。结果显示56%(226/407)的MFS患者至少有一次眼部诊断登记,风险比为8.0(95%CI 7.0至9.2),涉及7个主要诊断组,且手术和眼部药物使用显著增加。结论强调需要全面且经验丰富的眼科监测。

要点

  • 马方综合征患者中56%(226/407)至少有一次眼部诊断登记,风险比为8.0(95%CI 7.0至9.2)。
  • 眼部受累涉及7个主要诊断组,包括晶状体、脉络膜和视网膜、眼肌及屈光、青光眼等。
  • 马方综合征患者的手术操作次数和眼部药物使用均显著增加。

核心结论

  • 这项全国性流行病学研究显示马方综合征患者眼部疾病负担沉重,强调需要全面且经验丰富的眼科监测。

研究设计与样本

  • 利用丹麦全国医疗登记数据,识别407例马方综合征患者的眼部疾病,并与40700名年龄和性别匹配的背景人群比较。

主要发现

  • 马方综合征患者中56%(226/407)至少有一次眼部诊断登记,风险比为8.0(95%CI 7.0至9.2)。
  • 11个主要诊断组中有7个受累,包括晶状体、脉络膜和视网膜、眼肌及双眼运动、调节和屈光、青光眼、视觉障碍和盲、玻璃体和眼球、巩膜、角膜、虹膜和睫状体。
  • 马方综合征患者的手术操作次数和眼部药物使用均显著增加。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ophthalmic complications are profound in Marfan syndrome (MFS). However, the overall burden is not well described. Our purpose was to evaluate the ocular morbidity in a nationwide perspective. METHODS: We identified the ocular morbidity in patients with MFS (n=407) by use of Danish national healthcare registers, using number and timing of hospital contacts related to ophthalmic diagnoses, to ophthalmic surgery and to prescriptions for ophthalmic medication. An age-matched and gender-matched background population (n=40 700) was used as comparator. RESULTS: Among MFS, 56% (226/407) of the patients had at least one registration of an ophthalmic diagnosis as inpatient or outpatient during the study period (HR of 8.0 (95% CI 7.0 to 9.2)). Seven out of 11 main groups of diagnoses were affected, including 'Lens', 'Choroid and retina', 'Ocular muscles, binocular movement, accommodation and refraction', 'Glaucoma', Visual disturbances and blindness', 'Vitreous body and globe', and 'Sclera, cornea, iris and ciliary body'. The number of surgical procedures as well as the use of ophthalmic medication in patients with MFS was significantly increased. CONCLUSION: This nationwide epidemiological study of ocular morbidity in MFS demonstrates a profound burden and emphasises the need for thorough and experienced ophthalmological surveillance.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Kjeldsen S, Andersen N, Groth K, et al. Ocular morbidity in Marfan syndrome: a nationwide epidemiological study. Br J Ophthalmol. 2022. PMID: 35318224. doi:10.1136/bjophthalmol-2021-320871

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。